Tarsus Pharmaceuticals, Inc. TARS Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s compensation and benefits?
- Tarsus Pharmaceuticals, Inc. (TARS) reported compensation and benefits of $8.53M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s compensation and benefits changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s compensation and benefits decreased by 14.1% year-over-year, from $9.93M to $8.53M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s compensation and benefits?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s compensation and benefits has grown at a 76.4% compound annual growth rate (CAGR), from $1.04M to $17.78M.